Skip to main content

Table 4 Circulating tumor cell (CTC) distribution

From: Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

CTC # CellSearch™ Ariol®
0 35 (71%) 25 (51%*)
1 to 4 8 (16%) 16 (33%*)
≥ 5 6 (12%) 8 (16%)
Positive % 29 49*
  1. * Significant difference (p < 0.01) with Z-test.